J Korean Med Sci.  2023 Jan;38(2):e5. 10.3346/jkms.2023.38.e5.

Case 6: A 27-Year-Old Woman With Dysarthria

• Lee D
• Jeon H
• Ahn Y
• Kim HJ
• Shin HE
• Koh JH

• KMID: 2537953
• DOI: http://doi.org/10.3346/jkms.2023.38.e5

Figure

• 

  Fig. 1 Neuroimaging studies. An initial computed tomography angiography of the head shows focal occlusion (arrow) of the left middle cranial artery proximal M2 superior division (A: axial image and B: coronal image). Magnetic resonance imaging of the head was also performed, and axial diffusion-weighted images (C–E) and the apparent diffusion coefficient (F) show multiple small areas of restricted diffusion in the left MCA territory, suggestive of an acute infarction.

• 

  Fig. 2 Echocardiograms. On transthoracic echocardiography, a paraspinal long-axis view shows a normal mitral valve (A) and trivial mitral regurgitation (B). Transesophageal echocardiography in mid-esophageal 88-degree two chamber view; the arrow points to vegetation on the mitral valve posterior leaflet (C). Three-dimensional transesophageal echocardiography showing the mass on the mitral valve leaflet (D, arrow).

Reference

1. George MG. Risk factors for ischemic stroke in younger adults: a focused update. Stroke. 2020; 51(3):729–735. PMID: 32078487.

2. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017; 377(12):1177–1187. PMID: 28930509.

3. Hamasaki N, Kuma H, Tsuda H. Activated protein C anticoagulant system dysfunction and thrombophilia in Asia. Ann Lab Med. 2013; 33(1):8–13. PMID: 23301217.

4. Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018; 378(21):2010–2021. PMID: 29791828.

5. Maaijwee NA, Rutten-Jacobs LC, Schaapsmeerders P, van Dijk EJ, de Leeuw FE. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol. 2014; 10(6):315–325. PMID: 24776923.

6. Holmqvist M, Simard JF, Asplund K, Arkema EV. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies. RMD Open. 2015; 1(1):e000168. PMID: 26719816.

7. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J. 2014; 35(19):1245–1254. PMID: 24366917.

8. Rasmussen KL, Philips M, Tripodi A, Goetze JP. Unexpected, isolated activated partial thromboplastin time prolongation: a practical mini-review. Eur J Haematol. 2020; 104(6):519–525. PMID: 32049377.

9. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295–306. PMID: 16420554.

10. Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019; 78(6):736–745. PMID: 30926722.

11. Ruiz-Irastorza G, Egurbide MV, Pijoan JI, Garmendia M, Villar I, Martinez-Berriotxoa A, et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus. 2006; 15(9):577–583. PMID: 17080912.

12. Espinola RG, Pierangeli SS, Gharavi AE, Harris EN. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost. 2002; 87(3):518–522. PMID: 11916085.

13. Carrión-Barberà I, Salman-Monte TC, Vílchez-Oya F, Monfort J. Neuropsychiatric involvement in systemic lupus erythematosus: a review. Autoimmun Rev. 2021; 20(4):102780. PMID: 33609799.

14. Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021; 52(7):e364–e467. PMID: 34024117.

15. Sonsöz MR, Tekin RD, Gül A, Buğra Z, Atılgan D. Treatment of Libman-Sacks endocarditis by combination of warfarin and immunosuppressive therapy. Turk Kardiyol Dern Ars. 2019; 47(8):687–690. PMID: 31802766.

16. Roldan CA, Sibbitt WL Jr, Qualls CR, Jung RE, Greene ER, Gasparovic CM, et al. Libman-Sacks endocarditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging. 2013; 6(9):973–983. PMID: 24029368.

17. Chen A, Stecker E, A Warden B. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020; 9(13):e017559. PMID: 32538234.

18. Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019; 78(10):1296–1304. PMID: 31092409.

19. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996; 335(19):1424–1430. PMID: 8875919.

20. Mattos P, Santiago MB. Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Clin Rheumatol. 2011; 30(2):165–171. PMID: 21207090.

21. Roldan CA, Gelgand EA, Qualls CR, Sibbitt WL Jr. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Cardiology. 2007; 108(4):331–337. PMID: 17299260.

22. Roldan CA, Sibbitt WL Jr, Greene ER, Qualls CR, Jung RE. Libman-Sacks endocarditis and associated cerebrovascular disease: the role of medical therapy. PLoS One. 2021; 16(2):e0247052. PMID: 33592060.